Almac Group announced the completion of a £20 million investment in its cold chain management capabilities with the opening of a 95,000 sq ft custom built cold store facility at its global headquarters in Northern Ireland. 

With over 30 years’ experience in the field of global distribution and management of temperature sensitive drug products, Almac says this expansion strengthens their ability to provide a best-in-class service to its growing global client base by ensuring efficient and effective delivery of both clinical supplies and commercial drug products.  

The new facility complements Almac’s existing global clinical supply and drug product capabilities by boasting over 3,000 pallet spaces including -15°C to -25°C storage capacity, additional 2°C – 8°C secondary production rooms, 3PL processing areas and a custom designed clinical labelling suite.  Supplementary office space has also been included to accommodate an additional 100 new employees who will be recruited as a result of the expansion.

Alan Armstrong, chief executive officer Almac Group said, “This new facility at our global headquarters expands our cold storage capacity by 300% and our frozen storage capabilities by over 50%, enabling us to better serve our clients, and ultimately patients, worldwide thereby maintaining our position as a global leader in the life sciences sector.”

This news comes just weeks after the company announced a £30 million investment in its new European campus based in Dundalk, Ireland, including a new QC laboratory, packaging facility for commercial drug products and a dedicated 79,000sq ft EU Distribution Centre for clinical trial supply.